Report Detail
Global Women’s Health Diagnostics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
- RnM3835528 |
- 25 November, 2019 |
- Global |
- 110 Pages |
- 360iResearch |
- Other
The Global Women’s Health Diagnostics Market is expected to grow from USD 29,563.84 Million in 2018 to USD 52,536.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.56%.
The positioning of the Global Women’s Health Diagnostics Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Women’s Health Diagnostics Market including are F. Hoffmann-La Roche AG, Hologic, Inc., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG, Abbott Laboratories, Alere Inc., Becton, Dickinson and Company, Biomérieux SA, GE Healthcare, and Koninklijke Philips N.V..
On the basis of Application, the Global Women’s Health Diagnostics Market is studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests.
On the basis of End User, the Global Women’s Health Diagnostics Market is studied across Diagnostic and Imaging Centers, Home Care, and Hospitals and Clinics.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on Women’s Health Diagnostics offered by the key players in the Global Women’s Health Diagnostics Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Women’s Health Diagnostics Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Women’s Health Diagnostics Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Women’s Health Diagnostics Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Women’s Health Diagnostics Market
The report answers questions such as:
1. What is the market size of Women’s Health Diagnostics market in the Global?
2. What are the factors that affect the growth in the Global Women’s Health Diagnostics Market over the forecast period?
3. What is the competitive position in the Global Women’s Health Diagnostics Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Women’s Health Diagnostics Market?
5. What are the opportunities in the Global Women’s Health Diagnostics Market?
6. What are the modes of entering the Global Women’s Health Diagnostics Market?
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Process
- 2.1.2. Research Framework
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.2. Forecasting Methodology
- 2.3. Research Outcome
- 2.3.1. Competitive Strategic Window
- 2.3.1.1. Leverage Zone
- 2.3.1.2. Vantage Zone
- 2.3.1.3. Speculative Zone
- 2.3.1.4. Bottleneck Zone
- 2.3.2. FPNV Positioning Matrix
- 2.3.2.1. Quadrants
- 2.3.2.1.1. Forefront
- 2.3.2.1.2. Pathfinders
- 2.3.2.1.3. Niche
- 2.3.2.1.4. Vital
- 2.3.2.2. Business Strategy
- 2.3.2.2.1. Business Growth
- 2.3.2.2.2. Industry Coverage
- 2.3.2.2.3. Financial Viability
- 2.3.2.2.4. Channel Support
- 2.3.2.3. Product Satisfaction
- 2.3.2.3.1. Value for Money
- 2.3.2.3.2. Ease of Use
- 2.3.2.3.3. Product Features
- 2.3.2.3.4. Customer Support
3. Executive Summary
- 3.1. Outlook in the Women’s Health Diagnostics Market
- 3.2. Opportunities in the Women’s Health Diagnostics Market
- 3.3. Geographical Analysis in the Women’s Health Diagnostics Market
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.1.1. Increasing instances of chronic and life style- related disorders in women
- 4.2.1.2. Awareness about fertility testing in women coupled with initiatives taken by health organizations and government
- 4.2.1.3. Adoption of point-of-care and rapid diagnostic tests
- 4.2.1.4. Availability of imaging and private diagnostic centres
- 4.2.1.5. PPP to develop the modern infrastructure of diagnostic imaging centres
- 4.2.2. Restraints
- 4.2.2.1. Limited technically skilled lab assistants
- 4.2.3. Opportunities
- 4.2.3.1. Improved and technically advanced healthcare infrastructure in emerging economies
- 4.2.3.2. Regulatory approvals for immunoassay diagnostics techniques
- 4.2.3.3. Growing focus on microfluidics and nanotechnology-based POC devices for diagnostic
- 4.2.3.4. Clinical trial assessment for the diagnosis of breast cancer
- 4.2.4. Challenges
- 4.2.4.1. High cost associated with procedures and diagnostic imaging systems
- 4.2.4.2. Stringent regulatory guidelines
- 4.2.1. Drivers
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Threat of New Entrants
- 4.3.2. Threat of Substitutes
- 4.3.3. Bargaining Power of Customers
- 4.3.4. Bargaining Power of Suppliers
- 4.3.5. Industry Rivalry
- 4.4. Industry Trends
5. Global Women’s Health Diagnostics Market, by Application
- 5.1. Overview
- 5.2. Market Sizing & Forecasting
- 5.3. Breast Cancer Testing
- 5.3.1. Biopsies
- 5.3.2. Blood Chemistries and Blood Cell Count Tests
- 5.3.3. Breast Cancer Tumor Marker Tests
- 5.3.4. Mammography
- 5.4. Cervical Cancer Testing
- 5.4.1. HPV Testing
- 5.4.2. PAP Smear
- 5.5. Infectious Disease Testing
- 5.5.1. HEPAtitis Testing
- 5.5.2. MRSA Testing
- 5.5.3. Tuberculosis Testing
- 5.5.4. Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
- 5.6. Osteoporosis Testing
- 5.6.1. Bone Densitometry
- 5.6.2. in Vitro Blood Tests
- 5.7. Ovarian Cancer Testing
- 5.7.1. Diagnostic Imaging Tests
- 5.7.2. Ovarian Cancer Tumor Marker Tests
- 5.8. Pregnancy and Fertility Testing
- 5.8.1. Fertility Monitors
- 5.8.2. Lab-Based Testing
- 5.8.3. Pregnancy Testing and Ovulation Prediction Kits
- 5.9. Prenatal Genetic Screening and Carrier Testing
- 5.9.1. Cystic Fibrosis
- 5.9.2. Down Syndrome and Edwards Syndrome
- 5.9.3. Torch Infections
- 5.10. Sexually Transmitted Disease Testing
- 5.10.1. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
- 5.10.2. HIV Testing
- 5.11. Ultrasound Tests
- 5.11.1. Breast Imaging
- 5.11.2. OB/GYN Imaging
6. Global Women’s Health Diagnostics Market, by End User
- 6.1. Overview
- 6.2. Market Sizing & Forecasting
- 6.3. Diagnostic and Imaging Centers
- 6.4. Home Care
- 6.5. Hospitals and Clinics
7. Global Women’s Health Diagnostics Market, by Geography
- 7.1. Americas
- 7.1.1. Overview
- 7.1.2. Market Sizing & Forecasting
- 7.1.3. Argentina
- 7.1.4. Canada
- 7.1.5. Mexico
- 7.1.6. United States
- 7.2. Asia-Pacific
- 7.2.1. Overview
- 7.2.2. Market Sizing & Forecasting
- 7.2.3. Australia
- 7.2.4. China
- 7.2.5. India
- 7.2.6. Japan
- 7.3. Europe, Middle East & Africa
- 7.3.1. Overview
- 7.3.2. Market Sizing & Forecasting
- 7.3.3. France
- 7.3.4. Germany
- 7.3.5. Italy
- 7.3.6. Spain
- 7.3.7. United Kingdom
8. Competitive Landscape
- 8.1. FPNV Positioning Matrix for Global Women’s Health Diagnostics Market
- 8.2. Market Vendor Ranking Analysis for Global Women’s Health Diagnostics Market
- 8.3. Competitive News Feed Analysis for Global Women’s Health Diagnostics Market
9. Company Usability Profiles
- 9.1. F. Hoffmann-La Roche AG
- 9.1.1. Overview
- 9.1.2. Strategy
- 9.1.3. SWOT
- 9.2. Hologic, Inc.
- 9.2.1. Overview
- 9.2.2. Strategy
- 9.2.3. SWOT
- 9.3. Perkinelmer Inc.
- 9.3.1. Overview
- 9.3.2. Strategy
- 9.3.3. SWOT
- 9.4. Quest Diagnostics Inc.
- 9.4.1. Overview
- 9.4.2. Strategy
- 9.4.3. SWOT
- 9.5. Siemens AG
- 9.5.1. Overview
- 9.5.2. Strategy
- 9.5.3. SWOT
- 9.6. Abbott Laboratories
- 9.7. Alere Inc.
- 9.8. Becton, Dickinson and Company
- 9.9. Biomérieux SA
- 9.10. GE Healthcare
- 9.11. Koninklijke Philips N.V.
10. Appendix
- 10.1. Discussion Guide
- 10.2. Top Reports
- 10.2.1. Global Wireless Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
- 10.2.2. Global Smart TV Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
- 10.2.3. Global Head-Up Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
- 10.2.4. Global Fall Detection System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
- 2.3.1. Competitive Strategic Window
Summary:
Get latest Market Research Reports on Women’s Health Diagnostics. Industry analysis & Market Report on Women’s Health Diagnostics is a syndicated market report, published as Global Women’s Health Diagnostics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025. It is complete Research Study and Industry Analysis of Women’s Health Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
